BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9931903)

  • 1. [Malignant melanoma of the skin: is there a curative surgical approach in locoregional metastasis?].
    Schmidt O; Merkel S; Meyer T; Göhl J; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1432-4. PubMed ID: 9931903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between the prognosis of skin melanomas and the timing of appearance of regional metastases].
    Vagner RI; Anisimov VV
    Vopr Onkol; 1986; 32(10):21-5. PubMed ID: 3776125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic principles of melanoma surgery].
    Walz MK
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():111-4. PubMed ID: 9101793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
    Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
    Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival with regional and distant metastases from cutaneous malignant melanoma.
    Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
    Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is surgical therapy of distant metastases of malignant melanoma worthwhile?].
    Göhl J; Meyer T; Haas C; Altendorf-Hofmann A; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():122-6. PubMed ID: 9101809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
    Hughes TM; A'Hern RP; Thomas JM
    Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
    Scheri RP; Essner R; Turner RR; Ye X; Morton DL
    Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic variables for patients with stage III malignant melanoma.
    Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
    Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.